FDA Drug Application (020741) for PRANDIN by NOVO NORDISK INC

Back to FDA Applications sponsored by NOVO NORDISK INC

Application Number020741
Product Number001
FormTABLET;ORAL
Dosage0.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NamePRANDIN
Active IngredientREPAGLINIDE

Active IngredientCount
List of drugs with Active Ingredient REPAGLINIDE4


Back to FDA Applications sponsored by NOVO NORDISK INC